Lewis acid-catalyzed tandem synthesis of 9

RSC Advances View Article Online

Published on 04 May 2016. Downloaded by Tsinghua University on 21/12/2016 08:36:27.

PAPER

Cite this: RSC Adv., 2016, 6, 47570

View Journal | View Issue

Lewis acid-catalyzed tandem synthesis of 9-sulfonylamino- and 9-arylfluorenes† Dayun Huang, Weiguang Yang, Jianlan Zhang, Xuesong Wang, Xinyan Wang* and Yuefei Hu* A Lewis acid-catalyzed three-step tandem synthesis of 9-arylfluorene was developed by simply

Received 12th February 2016 Accepted 3rd May 2016

heating a mixture of 2-formyl biphenyl, TsNCO and an arene. In the absence of arene, a two-step tandem synthesis of 9-sulfonylaminofluorene was achieved. These advances were mainly

DOI: 10.1039/c6ra03889a

attributed to the discovery of an anhydrous synthesis of N-tosyl arylaldimines from TsNCO and

www.rsc.org/advances

arylaldehydes.

Introduction When two benzene rings in diphenylmethane are coupled, the corresponding tricyclic uorene is formed. Fluorene has a nearly planar structure and is easily substituted by aryl groups on C9. Thus, numerous 9-aryluorenes 1 have been synthesized and used in various novel material applications.1 As shown in Fig. 1, the structural unit of 9-mesityluorene (1a) in the molecules 2–4 has been proven to be the best precursor to generate a stable radical on C9.2 The molecules containing two or more such unpaired electrons are called organic diradicals or polyradicals with open-shell structures,

Fig. 1

which have recently been the subject of intensive studies due to their fascinating photoelectric properties. A number of methods have been reported for the synthesis of 9-aryluorenes 1 in the literature.3–7 As shown in Scheme 1, three practical methods (a–c) starting from 2-carbonyl biphenyl 5 offered multiple choices for different applications.2a,b,5–7 The method-c7 seems highly attractive due to its tandem process to convert 5 into 1 in one-pot. However, a major drawback to this method has been the requirements of highly electron-rich Ar2 and Ar3 (such as indole, thiophene, multi-alkoxy substituted benzene, etc.).7b–d Since the diarylmethanol 7 has been conrmed to be an intermediate, these drawbacks must be caused by two facts: (a) the aldehyde group of 5 has low electrophilicity; (b) the hydroxyl group of 7 is a poor leaving group but a good nucleophile. These hypotheses have been supported by some published references, in which the reaction efficiency was improved signicantly by converting the hydroxyl group into the corresponding acetate.6b,7a

Structures of 1 and 2.

Department of Chemistry, Tsinghua University, Beijing 100084, P. R. China. E-mail: y@mail.tsinghua.edu.cn; [email protected]; Fax: +86-1062771149; Tel: +86-10-62795380 † Electronic supplementary information (ESI) available: 1H and 13C NMR spectra for products 12a–12t and 1a–1t. CIF le for the single crystal X-ray diffraction analysis of 1s (CCDC 1452989). For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra03889a

47570 | RSC Adv., 2016, 6, 47570–47578

Scheme 1

Four synthetic methods starting from 5.

This journal is © The Royal Society of Chemistry 2016

View Article Online

Paper

RSC Advances

Herein, we would like to report a new method-d for efficient synthesis of 9-aryluorene 1 from 2-formyl biphenyl 5, tosyl isocyanate (TsNCO, 8) and an arene. In this method, the aldehyde was in situ converted into a highly electrophilic N-tosylimine and a low nucleophilic TsNH2 was used as a good leaving group.


Results and discussion Based on the analysis of method-c, two issues should be considered in developing the new method starting from 2formyl biphenyl 5: (a) increasing the electrophilicity of the aldehyde; (b) using a leaving group with low nucleophilicity. It is well-known that N-tosylimine is signicantly more electrophilic than the corresponding aldehyde (for example: E ¼ 19.92 for PhCHO; E ¼ 11.50 for PhCH]NTs).8 Therefore, N-tosylimines can efficiently carry out Lewis acid-catalyzed aza-Friedel–Cras reactions.9 Thus, two conditional experiments catalyzed by FeCl3 were made. As shown in Scheme 2, no reaction occurred between 2-phenyl-benzaldehyde (5a) and mesitylene (10a). However, the desired product 1a was obtained in 98% yield from N-tosyl-2-phenyl-benzaldimine (9a) and 10a, in which 12a was isolated as the intermediate instead of the expected 11a. These results indicated that the reaction initially carried out an intramolecular aza-Friedel–Cras reaction followed by an intermolecular Friedel–Cras reaction. But, the tosylimine 9a was required to be pre-made from 5a in this process.10 Our investigation showed that N-tosylimines were most oen prepared by dehydration between aldehydes and TsNH2. Since some of these processes can be catalyzed by Lewis acids11 including FeCl3,11b we realized that a FeCl3-catalyzed three-step tandem synthesis of 1a starting from 5a may be achieved. Unfortunately, when the mixture of 5a, TsNH2 and 10a was treated by FeCl3, only N-tosylimine 9a was obtained in 36% yield. As shown in Scheme 3, the problem of FeCl3 losing its catalytic activity aer the dehydration (in step 1) may be caused by the fact that one molecule of H2O formed and coordinated strongly with FeCl3. Thus, our attention was focused on two processes that convert an aldehyde into the corresponding N-tosylimine without the formation of H2O. As shown in Scheme 4, when TsNTeO12a or TsNSO12b reacted with an ArCHO, the desired

Scheme 2

Two conditional experiments from 5a and 9a.


Scheme 3

A failed tandem synthesis and possible reasons.

Scheme 4

Anhydrous syntheses of N-tosyl arylaldimines.

ArCH]NTs was synthesized efficiently via a [2 + 2] cycloaddition followed by a [2 + 2] cycloreversion. Yet, these processes were rarely used in the literature possibly due to inaccessible reagents, high cost and unpleasant smell. To our surprise, the structurally similar TsNCO was never used for such purpose even though it is a very cheap commercially available product and CO2 should be only by-product. However, a very careful investigation showed that the reaction between TsNCO and 4-MeC6H4CHO (13) was reported by King13 in 1960, but it failed to give the desired 4-MeC6H4CH] NTs (14). King concluded that the failure was caused by the poor hydrolytic stability of 14 since only the hydrolyzed products (13 and TsNH2) of 14 were isolated from the reaction. Since then, no further study was reported for the reaction between TsNCO and aryl aldehydes in the literature. Clearly, we now know that this conclusion is wrong because 14 has been prepared by many different methods and can be puried by chromatography or recrystallization.14 Thus, we were encouraged to retest the reaction described in Scheme 2, but in the presence of one equivalent of TsNCO. As shown in Scheme 5, when the mixture of 5a and TsNCO in mesitylene was treated by FeCl3 at 80 C for 1 h, the desired product 1a was obtained in 98% yield. As was expected, both 9a and 12a were isolated from the reaction as intermediates. Therefore, a method for highly efficient synthesis of 1a was established. As shown in Scheme 6, this reaction is a Lewis acidcatalyzed and TsNCO-mediated three-step tandem reaction. FeCl3 serves as a versatile Lewis acid to catalyze each of steps even though they have different mechanisms. Although no atom of TsNCO appears in the molecule of 1a, TsNCO plays three vital roles: (a) an anhydrous preparation of 9a was

Scheme 5

Tandem synthesis of 1a from 5a in one-pot.

RSC Adv., 2016, 6, 47570–47578 | 47571

View Article Online


RSC Advances

Scheme 6

Table 1

Paper

A proposed mechanism.

The reaction conditions for 12a and 1aa

Entry

Lewis acid (mol%)

Solvent

12ab (%)

1ab (%)

1 2 3 4 5 6c 7d 8d 9 10 11 12e

FeCl3 (10) Bi(OTf)3 (10) BF3$Et2O (30) Cu(OTf)2 (10) FeCl3 (5) FeCl3 (10) FeCl3 (10) Bi(OTf)3 (10) BF3$Et2O (30) Cu(OTf)2 (10) Cu(OTf)2 (10) Cu(OTf)2 (10)

Mesitylene Mesitylene Mesitylene Mesitylene Mesitylene Mesitylene DCE DCE DCE DCE CCl4 CCl4

0 82 41 52 ND ND 14 28 33 39 62 96

98 15 0 0 79 73 NA NA NA NA NA NA

as a catalyst (entry 8). Luckily, the reaction catalyzed by BF3$Et2O or Cu(OTf)2 gave 12a as a single product (entries 9–10). These results indicated that both FeCl3 and Bi(OTf)3 are strong catalysts for the conversion of 12a into uorene cation 15. Thus, the in situ formed highly active 15 may attack 12a to give lower polymers in the absence of a nucleophile (such as mesitylene). However, both BF3$Et2O and Cu(OTf)2 are weak catalysts and they could not catalyze the conversion of 12a into 15 at all. We interestingly observed that product 12a was precipitated out of the reaction mixture when CCl4 was used as a solvent (entry 11), by which the reaction equilibria were irreversibly shied towards the products 12a. Entry 12 showed that 12a was obtained in 96% yield when the reaction time was extended to 4.5 h. Finally, the entries 1 and 12 were assigned as the standard conditions for the syntheses of the derivatives of 1a and 12a, respectively. As shown in Scheme 7, the products 12a–12t were synthesized in satisfactory yields by simply heating the reactants and Cu(OTf)2 together. The lower yields of 12f–12j may be caused by the electron effect of Ar2, by which the nucleophilicity of Ar2 was decreased. No signicant inuence was observed by using different Ar1 (12k–12m). As was expected, the products 12q–12t were synthesized smoothly by using other commercial sulfonyl isocyanates (PhSO2NCO or 4-Cl-C6H4SO2NCO). As shown in Scheme 8, all tested products were obtained in excellent yields except 1e–1i, in which the electron effect of substituents led to lower nucleophilicity of Ar2. No signicant electron effect was observed when Ar1 was substituted by

a

A mixture of 5a (0.5 mmol) and TsNCO (0.6 mmol) in a solvent (2 mL) was heated at 80 C for 1 h in the presence of a Lewis acid. b Isolated yields were obtained. c Reaction proceeded at 70 C. d Large amounts of lower polymers were isolated. e 4.5 h were used.

achieved in situ by using TsNCO as a substrate; (b) the electrophilicity of imine group in 9a is signicantly promoted by the tosyl group; (c) neutral TsNH2 was used as a leaving group with low nucleophilicity. Next, the reaction conditions for the synthesis of 1a were optimized. As shown in Table 1, four popular Lewis acids (entries 1–4) were tested and only FeCl3 (entry 1) showed highly catalytic activity. When the reaction was catalyzed by 5 mol% of FeCl3 (entry 5) or proceeded at 70 C (entry 6), the yield of 1a was decreased signicantly. Since 9-tosylamino-uorene 12a is our key intermediate, we decided to develop a two-step tandem synthesis for it, too. However, when the mixture of 5a and TsNCO in DCE was treated by FeCl3 (entry 7), the desired 12a was obtained in only 14% yield and the major product was lower polymers. Similar results were obtained also by using Bi(OTf)3

47572 | RSC Adv., 2016, 6, 47570–47578

Scheme 7

The scope of 9-sulfonylaminofluorenes 12.


View Article Online

Paper

RSC Advances


Conclusions In conclusion, we have done four works in this article. (a) A strategy for the synthesis of 9-aryluorenes was proposed by using N-tosyl arylaldimine as an alternative of benzaldehyde. (b) An anhydrous preparation of N-tosyl arylalimine in situ was achieved by reaction between TsNCO and an aryl aldehyde. (c) A Cu(OTf)2-catalyzed two-step tandem synthesis of 9-sulfonylaminouorenes was established by simply heating the mixture of 2-formyl biphenyl and TsNCO. (d) A FeCl3-catalyzed three-step tandem synthesis of 9-aryluorenes was achieved by simply heating the mixture of 2-formyl biphenyl, TsNCO and an arene.

Experimental General information All melting points were determined on a Yanaco melting point apparatus and are uncorrected. IR spectra were recorded as KBr pellets on a Nicolet FT-IR 5DX spectrometer. The 1H NMR (300 or 400 MHz) and 13C NMR (75 or 100 MHz) spectra were recorded on a JEOL JNM-ECA spectrometers 300 or 400 in CDCl3 or DMSO-d6. TMS was used as an internal reference and J values are given in Hz. HRMS were obtained on a Bruker micrOTOF-Q II spectrometer. A typical procedure for preparation of 9-[(4-methylphenyl) sulfonylamino]uorene (12a)

Scheme 8

The scope of 9-arylfluorenes 1.

To a stirred mixture of 2-formyl biphenyl (5a, 91 mg, 0.5 mmol) and Cu(OTf)2 (18 mg, 0.05 mmol) in CCl4 (3 mL) was added TsNCO (118 mg, 0.6 mmol). Aer the mixture was heated at 80 C for 4.5 h, the solvent was then removed off in vacuum. The residue was puried by ash chromatography [silica gel, 20% EtOAc in petroleum ether (60–90 C)] to give 161 mg (96%) of product 12a as a white solid, mp 200–201 C (lit.9b mp 199–201 C); 1H NMR (400 MHz, CDCl3) d 7.92 (d, J ¼ 8.2 Hz, 2H), 7.58 (d, J ¼ 7.8 Hz, 2H), 7.39 (d, J ¼ 8.3 Hz, 2H), 7.35–7.31 (m, 2H), 7.20– 7.19 (m, 4H), 5.36 (d, J ¼ 9.6 Hz, 1H), 4.78 (d, J ¼ 9.6 Hz, 1H), 2.50 (s, 3H); 13C NMR (100 MHz, CDCl3) d 143.7, 143.3 (2C), 140.0 (2C), 138.4, 129.9 (2C), 128.9 (2C), 127.8 (2C), 127.3 (2C), 125.2 (2C), 119.9 (2C), 58.3, 21.6. The products 12b–12t were prepared by the similar procedure. 2-Methyl-9-[(4-methylphenyl)sulfonylamino]uorene (12b)

Fig. 2

The structure of product 1s.

different groups. When higher electron-rich Ar3 were used as substrates, the reactions could proceed in DCE (1q–1t). For example, three equivalents of 1,3,5-trimethoxybenzene were good enough to give 1t in excellent yield. Under the standard conditions, 1a was prepared on a 10 gram scale in 92% yield. As shown in Fig. 2, the structure of product 1s was further conrmed by single crystal X-ray diffraction.


White solid, mp 203–204 C (lit.9b mp 209–210 C); 1H NMR (400 MHz, CDCl3) d 7.89 (d, J ¼ 8.3 Hz, 2H), 7.49 (d, J ¼ 7.3 Hz, 1H), 7.41–7.36 (m, 3H), 7.29–7.26 (m, 1H), 7.16–7.06 (m, 3H), 6.88 (s, 1H), 5.30 (d, J ¼ 9.2 Hz, 1H), 4.71 (d, J ¼ 9.2 Hz, 1H), 2.48 (s, 3H), 2.26 (s, 3H); 13C NMR (100 MHz, CDCl3) d 143.7, 143.6, 143.3, 140.1, 138.8, 137.8, 137.3, 129.9 (2C), 129.6, 128.8, 127.4 (2C), 127.3, 125.9, 125.1, 119.6, 119.5, 58.3, 21.5, 21.4. 4-Methyl-9-[(4-methylphenyl)sulfonylamino]uorene (12c) White solid, mp 192–193 C (lit.9b mp 184–186 C); 1H NMR (300 MHz, CDCl3) d 7.92 (d, J ¼ 8.1 Hz, 2H), 7.72 (d, J ¼ 8.1 Hz, 1H), RSC Adv., 2016, 6, 47570–47578 | 47573

View Article Online

RSC Advances

7.41–7.32 (m, 3H), 7.26–7.18 (m, 2H), 7.10–7.02 (m, 3H), 5.34 (d, J ¼ 9.6 Hz, 1H), 4.74 (d, J ¼ 9.3 Hz, 1H), 2.60 (s, 3H), 2.50 (s, 3H); 13 C NMR (75 MHz, CDCl3) d 143.7 (2C), 143.5, 140.9, 138.5, 138.0, 133.1, 131.2, 129.8 (2C), 128.8, 127.5, 127.3, 127.2 (2C), 125.1, 123.0, 122.5, 58.2, 21.6, 20.7.


2-Isopropyl-9-[(4-methylphenyl)sulfonylamino]uorene (12d) White solid, mp 169–170 C (lit.9b mp 178–180 C); 1H NMR (400 MHz, CDCl3) d 7.92 (d, J ¼ 7.8 Hz, 2H), 7.54–7.46 (m, 2H), 7.41 (d, J ¼ 7.8 Hz, 2H), 7.33–7.20 (m, 4H), 6.97 (s, 1H), 5.35 (d, J ¼ 9.2 Hz, 1H), 4.82 (d, J ¼ 9.2 Hz, 1H), 3.29–3.23 (m, 1H), 2.51 (s, 3H), 1.27 (d, J ¼ 4.1 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 144.0, 143.9, 143.2, 139.4, 138.5, 138.4, 135.5, 132.1, 130.0 (2C), 129.0, 127.9, 127.8, 127.3 (2C), 125.2, 120.1, 119.8, 58.2, 38.0, 23.0 (2C), 21.6. 2-Phenyl-9-[(4-methylphenyl)sulfonylamino]uorene (12e) White solid, mp 217–219 C (lit.9b mp 188–190 C); 1H NMR (400 MHz, DMSO-d6) d 8.46 (d, J ¼ 8.7 Hz, 1H), 7.93 (d, J ¼ 7.8 Hz, 2H), 7.86–7.81 (m, 2H), 7.64 (d, J ¼ 7.8 Hz, 1H), 7.51–7.32 (m, 9H), 6.75 (s, 1H), 5.44 (d, J ¼ 8.2 Hz, 1H), 2.42 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.4, 144.2, 142.8, 139.5, 139.3, 139.1, 138.8, 138.7, 129.7 (2C), 128.7 (2C), 128.4, 127.5, 127.2, 126.9, 126.5 (2C), 126.1 (2C), 124.7, 122.6, 120.4, 120.0, 57.6, 20.8. 2-Methoxy-9-[(4-methylphenyl)sulfonylamino]uorene (12f) White solid, mp 194–195 C (lit.9b mp 188–190 C); 1H NMR (300 MHz, DMSO-d6) d 8.44 (d, J ¼ 8.6 Hz, 1H), 7.92 (d, J ¼ 8.3 Hz, 2H), 7.67 (d, J ¼ 8.3 Hz, 2H), 7.51 (d, J ¼ 7.9 Hz, 2H), 7.36–7.31 (m, 1H), 7.21–7.11 (m, 2H), 6.93–6.90 (m, 1H), 6.34 (d, J ¼ 2.1 Hz, 1H), 5.29 (d, J ¼ 8.3 Hz, 1H), 3.60 (s, 3H), 2.44 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 159.3, 145.8, 143.6, 143.0, 139.6, 139.5, 132.3, 129.9 (2C), 128.6, 126.7 (2C), 126.4, 124.7, 121.1, 119.3, 114.9, 109.8, 57.7, 55.2, 21.0. 2-Triuoromethoxy-9-[(4-methylphenyl)sulfonylamino]uorene (12g) White solid, mp 183–184 C (lit.9b mp 181–183 C); 1H NMR (400 MHz, DMSO-d6) d 8.54 (d, J ¼ 8.7 Hz, 1H), 7.93–7.89 (m, 3H), 7.82 (d, J ¼ 7.2 Hz, 1H), 7.50 (d, J ¼ 8.2 Hz, 2H), 7.42–7.28 (m, 2H), 7.16 (d, J ¼ 8.0 Hz, 1H), 6.60 (s, 1H), 5.41 (d, J ¼ 8.7 Hz, 1H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 147.7, 146.2, 144.2, 143.1, 139.2, 138.8, 138.1, 129.9 (2C), 128.8, 128.0, 126.7 (2C), 124.9, 121.6, 120.5, 118.8, 117.5, 57.6, 20.9. 2-Fluoro-9-[(4-methylphenyl)sulfonylamino]uorene (12h) White solid, mp 203–204 C (lit.9a mp 198–200 C); 1H NMR (400 MHz, DMSO-d6) d 8.50 (d, J ¼ 8.2 Hz, 1H), 7.90 (d, J ¼ 8.3 Hz, 2H), 7.84–7.77 (m, 2H), 7.50 (d, J ¼ 7.8 Hz, 2H), 7.38 (t, J ¼ 7.6 Hz, 1H), 7.25–7.19 (m, 2H), 7.07 (d, J ¼ 7.6 Hz, 1H), 6.64 (d, J ¼ 9.2 Hz, 1H), 5.36 (d, J ¼ 8.3 Hz, 1H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 161.9 (d, J ¼ 242.2 Hz), 146.5 (d, J ¼ 7.6 Hz), 143.8, 143.0, 139.1, 138.6, 135.9, 129.9 (2C), 128.7, 127.3, 126.7 (2C), 124.8, 121.7 (d, J ¼ 8.6 Hz), 120.0, 115.5 (d, J ¼ 22.9 Hz), 111.9 (d, J ¼ 23.9 Hz), 57.6, 21.0.

47574 | RSC Adv., 2016, 6, 47570–47578

Paper

2-Chloro-9-[(4-methylphenyl)sulfonylamino]uorene (12i) White solid, mp 213–215 C (lit.9b mp 208–210 C); 1H NMR (300 MHz, DMSO-d6) d 8.48 (d, J ¼ 8.6 Hz, 1H), 7.89 (d, J ¼ 7.9 Hz, 2H), 7.79 (d, J ¼ 7.9 Hz, 2H), 7.50 (d, J ¼ 8.3 Hz, 2H), 7.42–7.36 (m, 1H), 7.27 (t, J ¼ 7.2 Hz, 1H), 7.11 (d, J ¼ 7.5 Hz, 1H), 6.68 (s, 1H), 5.36 (d, J ¼ 8.6 Hz, 1H), 2.46 (s, 3H); 13C NMR (75 MHz, DMSO-d6) d 145.9, 143.6, 143.0, 139.0, 138.4, 138.3, 131.8, 129.8 (2C), 128.6, 128.4, 127.8, 126.7 (2C), 124.8, 124.7, 121.5, 120.2, 57.5, 20.9. 2-Chloro-9-[(4-methylphenyl)sulfonylamino]uorene (12j) White solid, mp 203–204 C (lit.9a mp 208–210 C); 1H NMR (400 MHz, DMSO-d6) d 8.53 (d, J ¼ 8.2 Hz, 1H), 8.01–7.90 (m, 3H), 7.72–7.70 (m, 1H), 7.52–7.36 (m, 4H), 7.23 (d, J ¼ 7.6 Hz, 1H), 6.86 (s, 1H), 5.46 (d, J ¼ 8.7 Hz, 1H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 147.9, 147.6, 143.9 (2C), 139.3, 138.2, 130.3 (2C), 129.4 (2C), 128.1 (q, J ¼ 31.5 Hz), 127.1 (2C), 126.2, 125.3, 124.6 (q, J ¼ 270.8 Hz), 121.7, 121.5, 121.1, 58.0, 21.3. 3-Methyl-9-[(4-methylphenyl)sulfonylamino]uorene (12k) White solid, mp 192–193 C (lit.9b mp 189–191 C); 1H NMR (400 MHz, CDCl3) d 7.91 (d, J ¼ 8.2 Hz, 2H), 7.54 (d, J ¼ 7.8 Hz, 1H), 7.38 (d, J ¼ 7.3 Hz, 3H), 7.32–7.30 (m, 1H), 7.17 (d, J ¼ 4.1 Hz, 2H), 7.04–6.99 (m, 2H), 5.30 (d, J ¼ 9.2 Hz, 1H), 4.73 (d, J ¼ 9.6 Hz, 1H), 2.49 (s, 3H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3) d 143.9, 143.7, 140.6, 140.1, 140.0, 138.9, 138.4, 129.9 (2C), 128.6, 128.7, 127.3, 127.5 (2C), 125.1, 124.8, 120.5, 119.7, 58.0, 21.6, 21.5. 3-Methoxy-9-[(4-methylphenyl)sulfonylamino]uorene (12l) White solid, mp 178–179 C; IR (KBr) n 3306, 2836, 1589, 1430, 1327, 1164 cm1; 1H NMR (300 MHz, CDCl3) d 7.89 (d, J ¼ 8.3 Hz, 2H), 7.43–7.36 (m, 4H), 7.28–7.22 (m, 1H), 7.09 (d, J ¼ 4.4 Hz, 2H), 6.82–6.79 (m, 1H), 6.61 (s, 1H), 5.26 (d, J ¼ 9.6 Hz, 1H), 4.82 (d, J ¼ 9.3 Hz, 1H), 3.67 (s, 3H), 2.47 (s, 3H); 13C NMR (75 MHz, CDCl3) d 159.9, 145.3, 143.7, 142.9, 140.0, 138.6, 132.6, 129.9 (2C), 128.9, 127.3 (2C), 126.5, 124.9, 120.7, 119.0, 115.6, 110.0, 58.3, 55.4, 21.6. HRMS (ESI-TOF) (m/z): calcd for C21H19NO3S, [M + Na]+ 388.0978; found 388.0971. 3-Chloro-9-[(4-methylphenyl)sulfonylamino]uorene (12m) White solid, mp 165–166 C (lit.9b mp 156–158 C); 1H NMR (400 MHz, DMSO-d6) d 8.47 (d, J ¼ 8.2 Hz, 1H), 7.91 (d, J ¼ 8.2 Hz, 2H), 7.85 (d, J ¼ 7.8 Hz, 1H), 7.49 (d, J ¼ 7.8 Hz, 2H), 7.38 (t, J ¼ 7.4 Hz, 1H), 7.29–7.24 (m, 2H), 7.08–7.02 (m, 2H), 5.33 (d, J ¼ 8.4 Hz, 1H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.3, 143.0, 142.7, 141.7, 139.2, 138.3, 133.5, 129.8 (2C), 128.7, 128.3, 127.2, 126.7 (2C), 126.3, 124.9, 120.7, 120.3, 57.3, 21.1. 2,6-Dimethyl-9-[(4-methylphenyl)sulfonylamino]uorene (12n) White solid, mp 211–212 C; IR (KBr) n 3307, 1595, 1436, 1328, 1157 cm1; 1H NMR (400 MHz, DMSO-d6) d 8.33 (d, J ¼ 7.8 Hz, 1H), 7.89 (d, J ¼ 7.8 Hz, 2H), 7.59 (d, J ¼ 7.3 Hz, 1H), 7.52–7.49


View Article Online

Paper

RSC Advances

(m, 2H), 7.15 (d, J ¼ 7.4 Hz, 1H), 7.00 (d, J ¼ 7.8 Hz, 1H), 6.89 (d, J ¼ 7.3 Hz, 1H), 6.58 (s, 1H), 5.22 (d, J ¼ 7.8 Hz, 1H), 2.47 (s, 3H), 2.34 (s, 3H), 2.21 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.5, 142.9, 140.9, 139.8, 139.6, 137.9, 137.0, 136.8, 129.8 (2C), 129.0, 127.8, 126.7 (2C), 125.5, 124.5, 120.2, 119.7, 57.4, 21.1 (2C), 21.0. HRMS (ESI-TOF) (m/z): calcd for C22H21NO2S, [M + Na]+ 386.1185; found 386.1187.


2-Methyl-6-chloro-2-9-[(4-methylphenyl)sulfonylamino]uorene (12o) White solid, mp 207–208 C; IR (KBr) n 3269, 1569, 1430, 1333, 1161 cm1; 1H NMR (400 MHz, DMSO-d6) d 8.28 (d, J ¼ 8.7 Hz, 1H), 7.77 (d, J ¼ 8.2 Hz, 2H), 7.66 (d, J ¼ 1.8 Hz, 1H), 7.54 (d, J ¼ 7.8 Hz, 1H), 7.37 (d, J ¼ 8.2 Hz, 2H), 7.12–7.09 (m, 1H), 7.02 (d, J ¼ 7.8 Hz, 1H), 6.91 (d, J ¼ 8.0 Hz, 1H), 6.39 (s, 1H), 5.08 (d, J ¼ 8.2 Hz, 1H), 2.40 (s, 3H), 2.12 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.5, 143.0, 142.5, 141.8, 139.4, 137.7, 135.8, 133.5, 129.9 (2C), 129.3, 126.7 (2C), 126.6, 126.2, 125.5, 120.4, 119.9, 57.2, 21.1, 21.0. HRMS (ESI-TOF) (m/z): calcd for C21H18ClNO2S, [M + Na]+ 406.0639; found 406.0634. 3-Chloro-6-methyl-9-[(4-methylphenyl)sulfonylamino]uorene (12p) White solid, mp 197–198 C; IR (KBr) n 3290, 1579, 1424, 1338, 1163 cm1; 1H NMR (400 MHz, DMSO-d6) d 8.42 (d, J ¼ 8.3 Hz, 1H), 7.88 (d, J ¼ 7.8 Hz, 2H), 7.72 (s, 1H), 7.49 (d, J ¼ 8.4 Hz, 2H), 7.32–7.31 (m, 1H), 7.19–7.14 (m, 2H), 7.10 (d, J ¼ 8.2 Hz, 1H), 6.87 (d, J ¼ 6.4 Hz, 1H), 5.29 (d, J ¼ 8.7 Hz, 1H), 2.58 (s, 3H), 2.46 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.8, 143.1, 142.9, 142.1, 139.3, 136.1, 133.2, 133.1, 130.8, 129.8 (2C), 128.0, 126.7 (3C), 126.1, 122.5, 122.4, 57.2, 21.1, 20.2. HRMS (ESI-TOF) (m/z): calcd for C21H18ClNO2S, [M + Na]+ 406.0639; found 406.0642. 9-(Phenyl-sulfonylamino)uorene (12q)

15

White solid, mp 203–204 C; 1H NMR (400 MHz, DMSO-d6) d 8.55 (d, J ¼ 7.8 Hz, 1H), 8.07 (d, J ¼ 7.8 Hz, 2H), 7.80–7.70 (m, 4H), 7.40–7.36 (m, 2H), 7.25–7.21 (m, 2H), 7.03 (d, J ¼ 7.3 Hz, 2H), 5.40 (d, J ¼ 8.2 Hz, 1H); 13C NMR (400 MHz, DMSO-d6) d 143.9 (2C), 142.2, 139.5 (2C), 132.7, 129.5 (2C), 128.6 (2C), 127.6 (2C), 126.7 (2C), 124.8 (2C), 120.1 (2C), 57.8.

7.3 Hz, 2H), 5.42 (d, J ¼ 8.2 Hz, 1H); 13C NMR (400 MHz, DMSOd6) d 143.7 (2C), 141.1, 139.5 (2C), 137.4, 129.6 (2C), 128.7 (2C), 128.6 (2C), 127.6 (2C), 124.8 (2C), 120.2 (2C), 57.8. 2-Methyl-9-[(4-chlorophenyl)sulfonylamino]uorene (12t) White solid, mp 204–206 C; IR (KBr) n 3279, 1577, 1403, 1329, 1164 cm1; 1H NMR (400 MHz, DMSO-d6) d 8.60 (d, J ¼ 8.2 Hz, 1H), 8.01 (d, J ¼ 8.7 Hz, 2H), 7.81–7.76 (m, 3H), 7.40 (t, J ¼ 7.3 Hz, 1H), 7.26 (t, J ¼ 7.3 Hz, 1H), 7.19–7.10 (m, 2H), 6.93 (d, J ¼ 6.9 Hz, 1H), 5.36 (d, J ¼ 8.2 Hz, 1H), 2.60 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.5, 144.4, 141.6, 140.7, 137.8, 137.7, 133.1, 131.2, 129.9 (2C), 129.1, 129.0 (2C), 127.7, 127.4, 125.1, 123.4, 122.7, 58.0, 20.8. HRMS (ESI-TOF) (m/z): calcd for C20H16ClNO2S, [M + Na]+ 392.0482; found 392.0480. A typical procedure for preparation of 9-mesityluorene (1a) To a stirred suspension of 2-formyl biphenyl (5a, 91 mg, 0.5 mmol) and FeCl3 (8 mg, 10 mol%) in mesitylene (2 mL) was added TsNCO (118 mg, 0.6 mmol). Aer the resultant mixture was heated at 80 C for 1 h, it was cooled down to room temperature. It was then subjected to pass a ash chromatography [silica gel, 1% EtOAc in petroleum ether (60–90 C)] to give 139 mg (98%) of product 1a as a colorless oil;7a 1H NMR (400 MHz, CDCl3) d 7.82 (d, J ¼ 7.4 Hz, 2H), 7.40–7.37 (m, 2H), 7.26–7.20 (m, 4H), 7.01 (s, 1H), 6.64 (s, 1H), 5.48 (s, 1H), 2.67 (s, 3H), 2.27 (s, 3H), 1.08 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.2 (2C), 140.9 (2C), 137.8, 137.7, 136.2, 133.8, 130.5, 128.8, 127.1 (2C), 126.8 (2C), 124.1 (2C), 120.0 (2C), 49.7, 21.7, 20.8, 18.6. The products 1b–1t were prepared by the similar procedure. 2-Methyl-9-mesityluorene (1b)7a White solid, mp 110–111 C; 1H NMR (400 MHz, CDCl3) d 7.96 (d, J ¼ 7.8 Hz, 1H), 7.40–7.36 (m, 1H), 7.23–7.22 (m, 2H), 7.14– 7.13 (m, 2H), 7.06–7.04 (m, 1H), 7.00 (s, 1H), 6.64 (s, 1H), 5.45 (s, 1H), 2.76 (s, 3H), 2.65 (s, 3H), 2.26 (s, 3H), 1.07 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.6, 147.5, 141.8, 138.9, 137.8, 137.7, 136.1, 134.2, 133.1, 130.5, 129.0, 128.7, 126.8, 126.7, 126.4, 124.0, 123.1, 121.6, 49.7, 21.6, 21.1, 20.8, 18.7. 4-Methyl-9-mesityluorene (1c)7a

2-Methyl-9-(phenyl-sulfonylamino)uorene (12r) White solid, mp 191–192 C (lit.9b mp 200–201 C); 1H NMR (400 MHz, DMSO-d6) d 8.48 (d, J ¼ 8.7 Hz, 1H), 8.04 (d, J ¼ 7.3 Hz, 2H), 7.79–7.69 (m, 4H), 7.39 (t, J ¼ 7.8 Hz, 1H), 7.23 (t, J ¼ 7.4 Hz, 1H), 7.17–7.10 (m, 2H), 7.04 (d, J ¼ 7.8 Hz, 1H), 6.87 (d, J ¼ 6.9 Hz, 1H), 5.32 (d, J ¼ 8.0 Hz, 1H), 2.58 (s, 3H); 13C NMR (100 MHz, DMSO-d6) d 144.3, 144.2, 142.3, 140.2, 137.3, 132.6 (2C), 130.7, 129.5 (2C), 128.6, 127.2, 126.9, 126.6 (2C), 124.7, 122.9, 122.2, 57.6, 20.4. 9-[(4-Chlorophenyl)sulfonylamino]uorene (12s)15 White solid, mp 217–219 C. 1H NMR (400 MHz, DMSO-d6) d 8.66 (d, J ¼ 8.3 Hz, 1H), 8.04 (d, J ¼ 8.7 Hz, 2H), 7.81–7.77 (m, 3H), 7.39 (t, J ¼ 7.4 Hz, 2H), 7.26 (t, J ¼ 7.3 Hz, 2H), 7.10 (d, J ¼ This journal is © The Royal Society of Chemistry 2016

White solid, mp 109–110 C; 1H NMR (400 MHz, CDCl3) d 7.95 (d, J ¼ 7.8 Hz, 1H), 7.39–7.35 (m, 1H), 7.22 (d, J ¼ 4.4 Hz, 2H), 7.14–7.12 (m, 2H), 7.06–7.03 (m, 1H), 6.99 (s, 1H), 6.63 (s, 1H), 5.44 (s, 1H), 2.75 (s, 3H), 2.64 (s, 3H), 2.25 (s, 3H), 1.07 (s, 3H); 13 C NMR (100 MHz, CDCl3) d 147.6, 147.5, 141.8, 138.9, 137.8, 137.6, 136.1, 134.2, 133.1, 130.5, 129.0, 128.7, 126.8, 126.7, 126.4, 124.0, 123.1, 121.5, 49.7, 21.7, 21.1, 20.8, 18.7. 2-Isopropyl-9-mesityluorene (1d)16 Colorless oil; 1H NMR (400 MHz, CDCl3) d 7.78–7.71 (m, 2H), 7.44–7.34 (m, 2H), 7.26–7.18 (m, 3H), 7.00 (s, 1H), 6.64 (s, 1H), 5.45 (s, 1H), 3.35–3.26 (m, 1H), 2.65 (s, 3H), 2.27 (s, 3H), 1.23 (d, J ¼ 6.4 Hz, 6H), 1.09 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.9, 147.1, 140.3, 139.8, 137.7, 137.6, 136.2, 134.1, 133.4, 130.9,

RSC Adv., 2016, 6, 47570–47578 | 47575

View Article Online

RSC Advances

130.5, 128.9, 128.0, 127.2, 126.9, 124.1, 120.2, 119.9, 49.6, 38.6, 23.0, 22.9, 21.7, 20.8, 18.6.


2-Methoxy-9-mesityluorene (1e)7a White solid, mp 110–111 C; 1H NMR (400 MHz, CDCl3) d 8.10 (d, J ¼ 7.8 Hz, 1H), 7.87–7.85 (m, 3H), 7.42–7.39 (m, 1H), 7.30 (t, J ¼ 7.2 Hz, 1H), 7.24–7.22 (m, 1H), 7.03 (s, 1H), 6.64 (s, 1H), 5.50 (s, 1H), 3.86 (s, 3H), 2.68 (s, 3H), 2.27 (s, 3H), 1.05 (s, 3H); 13C NMR (100 MHz, CDCl3) d 167.3, 148.4, 147.2, 145.4, 139.7, 137.7, 137.6, 136.4, 133.0, 130.6, 128.9, 128.8, 128.4, 127.0, 125.3, 124.3, 120.8, 119.7, 52.0, 49.7, 21.7, 20.8, 18.6.

2-(Triuoromethoxy)-9-mesityluorene (1f) Colorless oil; IR (KBr) n 3750, 2921, 1455, 1257 cm1; 1H NMR (400 MHz, CDCl3) d 7.79 (d, J ¼ 7.8 Hz, 2H), 7.39–7.36 (m, 1H), 7.27–7.19 (m, 3H), 7.06 (s, 1H), 7.01 (s, 1H), 6.66 (s, 1H), 5.46 (s, 1H), 2.65 (s, 3H), 2.27 (s, 3H), 1.08 (s, 3H); 13C NMR (100 MHz, CDCl3) d 149.1, 148.7, 147.4, 139.6, 137.7, 136.6, 132.8, 130.6, 129.0, 127.5 (2C), 127.1 (2C), 124.2, 120.7, 120.1 (2C), 119.8, 117.3, 49.8, 21.7, 20.8, 18.6. HRMS (ESI-TOF) (m/z): calcd for C23H19FO, [M H] 367.1309; found 367.1310. 2-Fluoro-9-mesityluorene (1g) Colorless oil; IR (KBr) n 3662, 3621, 3074, 1460 cm1; 1H NMR (400 MHz, CDCl3) d 7.74–7.69 (m, 2H), 7.36–7.32 (m, 1H), 7.20– 7.16 (m, 2H), 7.07–7.02 (m, 1H), 7.00 (s, 1H), 6.91–6.89 (m, 1H), 6.65 (s, 1H), 5.43 (s, 1H), 2.63 (s, 3H), 2.26 (s, 3H), 1.09 (s, 3H); 13 C NMR (100 MHz, CDCl3) d 162.7 (d, J ¼ 244.1 Hz), 149.4 (d, J ¼ 7.6 Hz), 147.0, 140.0, 137.6 (d, J ¼ 12.4 Hz, 2C), 136.8, 136.4, 133.2, 130.6, 128.9, 126.8 (d, J ¼ 11.5 Hz, 2C), 124.1, 120.9 (d, J ¼ 8.6 Hz), 119.6, 113.9 (d, J ¼ 22.9 Hz), 111.4 (d, J ¼ 22.9 Hz), 49.8, 21.6, 20.8, 18.6. HRMS (ESI-TOF) (m/z): calcd for C22H19F, [M + H]+ 303.1544; found 303.1542.

2-Chloro-9-mesityluorene (1h)7a Colorless oil; 1H NMR (400 MHz, CDCl3) d 7.76 (d, J ¼ 7.8 Hz, 1H), 7.70 (d, J ¼ 8.2 Hz, 1H), 7.38–7.32 (m, 2H), 7.26–7.18 (m, 3H), 7.01 (s, 1H), 6.65 (s, 1H), 5.43 (s, 1H), 2.63 (s, 3H), 2.27 (s, 3H), 1.09 (s, 3H); 13C NMR (100 MHz, CDCl3) d 148.9, 147.0, 139.8, 139.4, 137.7, 137.6, 136.5, 133.0, 132.8, 130.6, 128.9, 127.4, 127.1, 127.0, 124.4, 124.1, 120.9, 120.0, 49.6, 21.7, 20.8, 18.7.

2-(Triuoromethyl)-9-mesityluorene (1i)7a White solid, mp 104–105 C; 1H NMR (400 MHz, CDCl3) d 7.89– 7.84 (m, 2H), 7.64 (d, J ¼ 8.4 Hz, 1H), 7.46 (s, 1H), 7.40 (t, J ¼ 7.6 Hz, 1H), 7.30 (t, J ¼ 7.2 Hz, 1H), 7.23 (d, J ¼ 7.6 Hz, 1H), 7.03 (s, 1H), 6.66 (s, 1H), 5.49 (s, 1H), 2.66 (s, 3H), 2.27 (s, 3H), 1.05 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.9, 147.6, 144.2, 139.4, 137.7, 137.6, 136.7, 132.7, 130.7, 129.1 (q, J ¼ 31.5 Hz), 129.0, 128.4, 127.1, 124.5 (q, J ¼ 270.3 Hz), 124.3, 124.2 (q, J ¼ 4.3 Hz), 121.0 (q, J ¼ 3.6 Hz), 120.7, 120.1, 49.8, 21.7, 20.8, 18.7.

47576 | RSC Adv., 2016, 6, 47570–47578

Paper

3-Methoxy-9-mesityluorene (1j)7a White solid, 105–106 C; 1H NMR (400 MHz, CDCl3) d 7.70–7.66 (m, 2H), 7.33–7.29 (m, 1H), 7.14–7.12 (m, 2H), 6.99 (s, 1H), 6.92– 6.89 (m, 1H), 6.75 (s, 1H), 6.64 (s, 1H), 5.42 (s, 1H), 3.73 (s, 3H), 2.63 (s, 3H), 2.25 (s, 3H), 1.13 (s, 3H); 13C NMR (100 MHz, CDCl3) d 167.8, 159.7, 149.1, 146.6, 140.8, 137.9, 137.5, 136.1, 133.9, 130.5, 128.7, 126.7, 126.0, 123.9, 120.7, 119.1, 113.0, 109.5, 55.4, 49.8, 21.7, 20.8, 18.7. 2,6-Dimethyl-9-mesityluorene (1k) White solid, mp 107–108 C; IR (KBr) n 3004, 2916, 2859, 2732, 1448 cm1; 1H NMR (400 MHz, CDCl3) d 7.67 (d, J ¼ 7.8 Hz, 1H), 7.59 (s, 1H), 7.17 (d, J ¼ 7.4 Hz, 1H), 7.06 (d, J ¼ 7.8 Hz, 1H), 7.03–7.01 (m, 3H), 6.65 (s, 1H), 5.40 (s, 1H), 2.65 (s, 3H), 2.44 (s, 3H), 2.33 (s, 3H), 2.27 (s, 3H), 1.11 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.8, 144.1, 141.1, 138.3, 137.9, 137.6, 136.9, 136.3, 136.0, 134.3, 130.4, 128.7, 127.6 (2C), 124.7, 123.7, 120.2, 119.6, 49.2, 21.7, 21.6 (2C), 20.8, 18.7. HRMS (ESI-TOF) (m/z): calcd for C24H24, [M + Na]+ 335.1770; found 335.1774. 3,5-Dimethyl-9-mesityluorene (1l) Colorless oil; IR (KBr) n 3002, 2914, 2859, 1447 cm1; 1H NMR (400 MHz, CDCl3) d 7.77 (s, 1H), 7.13–7.09 (m, 3H), 7.06–7.02 (m, 2H), 6.99 (s, 1H), 6.63 (s, 1H), 5.40 (s, 1H), 2.76 (s, 3H), 2.64 (s, 3H), 2.47 (s, 3H), 2.26 (s, 3H), 1.08 (s, 3H); 13C NMR (100 MHz, CDCl3) d 148.0, 144.7, 142.0, 138.9, 137.8, 137.6, 136.1, 136.0, 134.4, 133.0, 130.4, 129.0, 128.7, 127.3, 126.6, 123.9, 123.6, 121.6, 49.3, 21.8, 21.7, 21.1, 20.8, 18.7. HRMS (ESI-TOF) (m/z): calcd for C24H24, [M + Na]+ 335.1770; found 335.1774. 3-Methyl-9-mesityluorene (1m) Colorless oil; IR (KBr) n 3697, 3012, 2858, 1444 cm1; 1H NMR (400 MHz, CDCl3) d 7.76 (d, J ¼ 7.8 Hz, 1H), 7.60 (s, 1H), 7.34– 7.30 (m, 1H), 7.19–7.17 (m, 2H), 7.09–7.01 (m, 2H), 6.98 (s, 1H), 6.62 (s, 1H), 5.42 (s, 1H), 2.63 (s, 3H), 2.42 (s, 3H), 2.24 (s, 3H), 1.09 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.5, 144.3, 141.0, 140.9, 137.8, 137.6, 136.3, 136.0, 134.0, 130.5, 128.7, 128.1, 127.0, 126.7, 124.1, 123.8, 120.5, 119.8, 49.3, 21.6, 21.7, 20.8, 18.6. HRMS (ESI-TOF) (m/z): calcd for C23H22, [M H] 297.1649; found 297.1642. 2-Methyl-6-chloro-9-mesityluorene (1n) Colorless oil; IR (KBr) n 3516, 3450, 2914, 1445 cm1; 1H NMR (400 MHz, CDCl3) d 7.69 (s, 1H), 7.61 (d, J ¼ 7.8 Hz, 1H), 7.17– 7.12 (m, 2H), 7.07–7.04 (m, 1H), 7.0 (s, 2H), 6.64 (s, 1H), 5.36 (s, 1H), 2.63 (s, 3H), 2.31 (s, 3H), 2.25 (s, 3H), 1.09 (s, 3H); 13C NMR (100 MHz, CDCl3) d 147.8, 145.2, 142.7, 137.9, 137.8, 137.6, 137.1, 136.3, 133.4, 132.7, 130.5, 128.8, 127.9, 126.5, 125.0, 124.8, 120.0, 119.9, 49.1, 21.7, 21.6, 20.8, 18.7. HRMS (ESI-TOF) (m/z): calcd for C23H21Cl, [M H] 331.1253; found 331.1254. 3-Chloro-5-methyl-9-mesityluorene (1o) Colorless oil; IR (KBr) n 3521, 2961, 2915, 1445 cm1; 1H NMR (300 MHz, CDCl3) d 7.90 (s, 1H), 7.20–7.09 (m, 4H), 7.04–7.01


View Article Online

Paper

(m, 1H), 6.99 (s, 1H), 6.63 (s, 1H), 5.37 (s, 1H), 2.72 (s, 3H), 2.62 (s, 3H), 2.25 (s, 3H), 1.06 (s, 3H); 13C NMR (75 MHz, CDCl3) d 148.1, 145.8, 143.4, 137.8, 137.7, 137.6, 136.3, 133.5, 133.4, 132.5, 130.5, 129.2, 128.8, 127.5, 126.3, 124.8, 123.2, 121.7, 49.3, 21.7, 21.0, 20.8, 18.7. HRMS (ESI-TOF) (m/z): calcd for C22H19F, [M H] 331.1253; found 331.1254.


3-Chloro-9-mesityluorene (1p) White solid, 91–92 C; IR (KBr) n 3494, 3449, 2912, 1610, 1442 cm1; 1H NMR (400 MHz, CDCl3) d 7.78–7.76 (m, 2H), 7.38 (t, J ¼ 7.8 Hz, 1H), 7.28–7.24 (m, 1H), 7.21–7.18 (m, 2H), 7.11 (d, J ¼ 7.8 Hz, 1H), 7.00 (s, 1H), 6.64 (s, 1H), 5.42 (s, 1H), 2.64 (s, 3H), 2.26 (s, 3H), 1.07 (s, 3H); 13C NMR (75 MHz, CDCl3) d 147.6, 145.4, 142.6, 139.7, 137.7, 137.6, 136.4, 133.2, 132.8, 130.6, 128.9, 127.8, 127.0 (2C), 125.1, 124.2, 120.2 (2C), 49.3, 21.6, 20.8, 18.6. HRMS (ESI-TOF) (m/z): calcd for C22H19Cl, [M H] 317.1103; found 317.1106. 9-(2,3,5,6-Tetramethylphenyl)uorene (1q) White solid, mp 120–122 C; IR (KBr) n 3507, 3449, 2914, 1443 cm1; 1H NMR (300 MHz, CDCl3) d 7.82 (d, J ¼ 6.0 Hz, 2H), 7.37– 7.33 (m, 2H), 7.24–7.20 (m, 4H), 6.92 (s, 1H), 5.56 (s, 1H), 2.55 (s, 3H), 2.37 (s, 3H), 2.01 (s, 3H), 0.99 (s, 3H); 13C NMR (75 MHz, CDCl3) d 147.9 (2C), 140.5 (2C), 136.6, 134.6, 134.0, 133.9, 133.3, 130.9, 127.1 (2C), 126.6 (2C), 124.0 (2C), 120.1 (2C), 50.6, 21.3, 20.2, 16.9, 14.9. HRMS (ESI-TOF) (m/z): calcd for C23H22, [M H]297.1649; found 297.1644. 9-(2,3,4,5,6-Pentamethylphenyl)uorene (1r)17 White solid, mp 120–122 C; 1H NMR (400 MHz, CDCl3) d 7.84 (d, J ¼ 7.6 Hz, 2H), 7.39–7.35 (m, 2H), 7.25–7.20 (m, 4H), 5.57 (s, 1H), 2.62 (s, 3H), 2.37 (s, 3H), 2.26 (s, 3H), 2.01 (s, 3H), 1.04 (s, 3H); 13C NMR (100 MHz, CDCl3) d 148.3 (2C), 140.4 (2C), 134.0, 133.8, 133.7, 133.5, 132.2, 127.0 (2C), 126.5 (2C), 123.9 (2C), 120.1 (3C), 51.0, 17.9, 17.6, 17.1, 16.4, 16.3. 9-(2,4-Dimethoxyphenyl)uorene (1s) White solid, mp 143–144 C; IR (KBr) n 3426, 2945, 2835, 1610, 1448, 1328 cm1; 1H NMR (400 MHz, CDCl3) d 7.77 (d, J ¼ 7.8 Hz, 2H), 7.36–7.32 (m, 4H), 7.25–7.21 (m, 2H), 6.57 (s, 1H), 6.47 (s, 1H), 6.24 (d, J ¼ 6.4 Hz, 1H), 5.58 (s, 1H), 3.92 (s, 3H), 3.74 (s, 3H); 13C NMR (100 MHz, CDCl3) d 159.3, 158.7, 148.3 (2C), 141.1 (2C), 128.6, 127.1 (2C), 126.9 (2C), 125.2 (2C), 122.4, 119.7 (2C), 104.4 (2C), 98.7, 55.6, 55.3. HRMS (ESI-TOF) (m/z): calcd for C21H18O2, [M + H]+ 303.1380; found 303.1384. 9-(2,4,6-Trimethoxyphenyl)uorene (1t)7a White solid, mp 116–117 C; 1H NMR (400 MHz, CDCl3) d 7.78 (d, J ¼ 8.0 Hz, 2H), 7.31–7.28 (m, 2H), 7.22–7.15 (m, 4H), 6.29 (d, J ¼ 2.4 Hz, 1H), 5.92 (d, J ¼ 2.4 Hz, 1H), 5.60 (s, 1H), 3.94 (s, 3H), 3.76 (s, 3H), 2.94 (s, 3H); 13C NMR (100 MHz, CDCl3) d 160.1, 159.7, 159.6, 148.7 (2C), 141.0 (2C), 126.4 (2C), 126.0 (2C), 123.6 (2C), 119.3 (2C), 110.6, 92.5, 91.0, 56.2, 55.7, 55.2, 43.6.


RSC Advances

Acknowledgements This work was supported by NNSFC (No. 21372142 and 21472107).

Notes and references 1 W.-Y. Wong, Coord. Chem. Rev., 2005, 249, 971–997. 2 Selected recent references, and references cited therein: (a) S. Nobusue, H. Miyoshi, A. Shimizu, I. Hisaki, K. Fukuda, M. Nakano and Y. Tobe, Angew. Chem., Int. Ed., 2015, 54, 2090–2094; (b) S. Das, S. Lee, M. Son, X. Zhu, W. Zhang, B. Zheng, P. Hu, Z. Zeng, Z. Sun, W. Zeng, R.-W. Li, K.-W. Huang, J. Ding, D. Kim and J. Wu, Chem.–Eur. J., 2014, 20, 11410–11420; (c) Y. Tian, K. Uchida, H. Kurata, Y. Hirao, T. Nishiuchi and T. Kubo, J. Am. Chem. Soc., 2014, 136, 12784–12793; (d) M. Miyoshi, S. Nobusue, A. Shimizu, I. Hisaki, M. Miyata and Y. Tobe, Chem. Sci., 2014, 5, 163–168. 3 By cyclization of polyalkynes, see: (a) K. Pati, G. P. Gomes, T. Harris, A. Hughes, H. Phan, T. Banerjee, K. Hanson and I. V. Alabugin, J. Am. Chem. Soc., 2015, 137, 1165–1180; (b) A. S. K. Hashmi, J. Hofmann, S. Shi, A. Schutz, M. Rudolph, C. Lothschutz, M. Wieteck, M. Buhrle, M. Woe and F. Rominger, Chem.–Eur. J., 2013, 19, 382– 389; (c) X.-C. Wang, R.-L. Yan, M.-J. Zhong and Y.-M. Liang, J. Org. Chem., 2012, 77, 2064–2068; (d) I. V. Alabugin, K. Gilmore, S. Patil, S. Manoharan, S. V. Kovalenko, R. J. Clark and I. Ghiviriga, J. Am. Chem. Soc., 2015, 130, 11535–11545. 4 By 9-arylation of uorenes, see: (a) Y.-Y. Ji, L.-L. Lu, Y.-C. Shi and L.-X. Shao, Org. Biomol. Chem., 2014, 12, 8488–8498; (b) C. Vila, V. Hornillos, M. Giannerini, M. Fananas-Mastral and B. L. Feringa, Chem.–Eur. J., 2014, 20, 13078–13083; (c) J. Zhang, A. Bellomo, A. D. Creamer, S. D. Dreher and P. J. Walsh, J. Am. Chem. Soc., 2012, 134, 13765–13772; (d) W. Wan, H. Du, J. Wang, Y. Le, H. Jiang, H. Chen, S. Zhu and J. Hao, Dyes Pigm., 2013, 96, 642–652; (e) J.-J. Chen, S. Onogi, Y.-C. Hsieh, C.-C. Hsiao, S. Higashibayashi, H. Sakurai and Y.-T. Wu, Adv. Synth. Catal., 2012, 354, 1551–1558; (f) V. Chandrasekhar, R. S. Narayanan and P. Thilagar, Organometallics, 2009, 28, 5883–5888. 5 References for method-a, see: Z. Liu, H. Tan, L. Wang, T. Fu, Y. Xia, Y. Zhang and J. Wang, Angew. Chem., Int. Ed., 2015, 54, 3056–3060. 6 References for method-b, see ref. 2a and b and: (a) S. Sarkar, S. Maiti, K. Bera, S. Jalal and U. Jana, Tetrahedron Lett., 2012, 53, 5544–5547; (b) G. Li, E. Wang, H. Chen, H. Li, Y. Liu and P. G. Wang, Tetrahedron, 2008, 64, 9033–9043; (c) Y. Wu, J. Zhang and Z. Bo, Org. Lett., 2007, 9, 4435–4438; (d) C. Xia and R. C. Advincula, Macromolecules, 2001, 34, 6922–6928. 7 References for method-c, see: (a) Q. Li, W. Xu, J. Hu, X. Chen, F. Zhang and H. Zheng, RSC Adv., 2014, 4, 27722–27725; (b) T. Das, A. Chakraborty and A. Sarkar, Tetrahedron Lett., 2014, 55, 5174–5178; (c) D. Das, S. Pratihar and S. Roy, Org. Lett., 2012, 14, 4870–4873; (d) S.-G. Wang, L. Han, M. Zeng, F.-L. Sun, W. Zhang and S.-L. You, Org. Biomol. Chem.,

RSC Adv., 2016, 6, 47570–47578 | 47577

View Article Online

RSC Advances

8


9

10 11

2012, 10, 3202–3209; (e) F.-L. Sun, M. Zeng, Q. Gu and S.-L. You, Chem.–Eur. J., 2009, 15, 8709–8712. R. Appel and H. Mayr, J. Am. Chem. Soc., 2011, 133, 8240– 8251. Selected references: (a) X. Yu and X. Lu, Tetrahedron Lett., 2011, 52, 2076–2079; (b) X. Yu and X. Lu, Adv. Synth. Catal., 2011, 353, 569–574; (c) P. Thirupathi and S. S. Kim, J. Org. Chem., 2010, 75, 5240–5249; (d) C.-R. Liu, M.-B. Li, C.-F. Yang and S.-K. Tian, Chem. Commun., 2008, 1249– 1251; (e) I. Alonso, J. Esquivias, R. Gomez-Arrayas and J. C. Carretero, J. Org. Chem., 2008, 73, 6401–6404; (f) J. Esquivias, R. G. Arrayas and J. C. Carretero, Angew. Chem., Int. Ed., 2006, 45, 629–633; (g) Y. Luo and C. J. Li, Chem. Commun., 2004, 1930–1931. B. E. Love, P. S. Raje and T. C. Williams, Synlett, 1994, 493– 494. Selected references: (a) J. T. Reeves, M. D. Visco, M. A. Marsini, N. Grinberg, C. A. Busacca, A. E. Mattson and C. H. Senanayake, Org. Lett., 2015, 17, 2442–2445; (b) X.-F. Wu, C. V.-L. Bray, L. Bechki and C. Darcel,

47578 | RSC Adv., 2016, 6, 47570–47578

Paper

12

13 14

15 16 17

Tetrahedron, 2009, 65, 7380–7384; (c) J. L. G. Ruano, J. Alem´ an and A. Parra, Org. Lett., 2005, 7, 179–182. (a) B. M. Trost and C. Marrs, J. Org. Chem., 1991, 56, 6468– 6470; (b) J. Sisko and S. M. Weinreb, J. Org. Chem., 1990, 55, 393–395. C. King, J. Org. Chem., 1960, 25, 352–356. Selected references: (a) R. Chawla, A. K. Singh and L. D. S. Yadav, Tetrahedron Lett., 2014, 55, 3553–3556; (b) W. Li, J. Gan and R. Fan, Tetrahedron Lett., 2010, 51, 4275– 4277; (c) R. Patel, V. P. Srivastava and L. D. S. Yadav, Adv. Synth. Catal., 2010, 352, 1610–1614; (d) S. L. Jain, V. B. Sharma and B. Sain, Tetrahedron Lett., 2004, 45, 4341–4343. M. M. Kremlev and S. I. Zlotchenko, Zh. Org. Khim., 1972, 8, 1059. W. T. Ford, T. B. Thompson, K. A. J. Snoble and J. M. Timko, J. Am. Chem. Soc., 1975, 97, 95–101. R. A. McClelland, F. L. Cozens, J. Li and S. Steenken, J. Chem. Soc., Perkin Trans. 2, 1996, 1531–1543.
